We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.43B
AUM Growth
+$75.3M
Cap. Flow
-$42M
Cap. Flow %
-1.22%
Top 10 Hldgs %
13.83%
Holding
1,352
New
131
Increased
487
Reduced
534
Closed
83

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$9.73M
2
MSFT icon
Microsoft
MSFT
+$6.54M
3
LMT icon
Lockheed Martin
LMT
+$5.54M
4
DD icon
DuPont de Nemours
DD
+$5.19M
5
AAPL icon
Apple
AAPL
+$4.57M

Sector Composition

Rank Sector Weight
1 Healthcare 14.45%
2 Technology 10.24%
3 Financials 10.23%
4 Industrials 9%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
126
Novo Nordisk
NVO
$216B
$6.26M 0.18%
300,950
-27,220
-8% -$675K
ELV icon
127
Elevance Health
ELV
$81.9B
$6.26M 0.18%
49,942
-1,985
-4% -$256K
APD icon
128
Air Products & Chemicals
APD
$66.3B
$6.24M 0.18%
44,857
-6,789
-13% -$941K
KMI icon
129
Kinder Morgan
KMI
$73.1B
$6.13M 0.18%
264,882
-12,883
-5% -$273K
MA icon
130
Mastercard
MA
$477B
$6.11M 0.18%
60,053
+4,021
+7% +$386K
IWD icon
131
iShares Russell 1000 Value ETF
IWD
$82B
$6.11M 0.18%
57,824
+10,642
+23% +$1.12M
UNP icon
132
Union Pacific
UNP
$183B
$6.09M 0.18%
62,497
+534
+0.9% +$49.9K
ENLK
133
DELISTED
EnLink Midstream Partners, LP
ENLK
$6.07M 0.18%
342,567
-1,975
-0.6% -$34.6K
CHE icon
134
Chemed
CHE
$6.78B
$6.04M 0.18%
42,825
-295
-0.7% -$41.1K
AMC icon
135
AMC Entertainment Holdings
AMC
$2.03B
$5.92M 0.17%
19,035
+6,250
+49% +$1.87M
CLB icon
136
Core Laboratories
CLB
$538M
$5.88M 0.17%
52,368
-1,559
-3% -$180K
ZTS icon
137
Zoetis
ZTS
$31.6B
$5.88M 0.17%
112,978
-8,246
-7% -$417K
USB icon
138
US Bancorp
USB
$99.6B
$5.87M 0.17%
136,929
+7,353
+6% +$312K
LLY icon
139
Eli Lilly
LLY
$1.07T
$5.79M 0.17%
72,137
+2,970
+4% +$238K
RTX icon
140
RTX Corp
RTX
$287B
$5.64M 0.16%
88,213
+878
+1% +$58.2K
ABT icon
141
Abbott
ABT
$180B
$5.61M 0.16%
132,712
+61
+0% +$2.61K
CBSH icon
142
Commerce Bancshares
CBSH
$8.5B
$5.55M 0.16%
183,384
+2,655
+1% +$79.2K
SWKS icon
143
Skyworks Solutions
SWKS
$9.06B
$5.52M 0.16%
72,510
+5,579
+8% +$389K
ESS icon
144
Essex Property Trust
ESS
$18.9B
$5.51M 0.16%
24,743
-60
-0.2% -$13.6K
B
145
Barrick Mining
B
$62.2B
$5.48M 0.16%
309,209
+141,487
+84% +$2.82M
BRK.A icon
146
Berkshire Hathaway Class A
BRK.A
$1.07T
$5.41M 0.16%
25
VGK icon
147
Vanguard FTSE Europe ETF
VGK
$30B
$5.4M 0.16%
110,856
+15,156
+16% +$729K
PEG icon
148
Public Service Enterprise Group
PEG
$39.8B
$5.38M 0.16%
128,438
-2,595
-2% -$114K
CAT icon
149
Caterpillar
CAT
$409B
$5.37M 0.16%
60,516
-4,292
-7% -$351K
AMT icon
150
American Tower
AMT
$77.7B
$5.35M 0.16%
47,195
-103
-0.2% -$11.8K

Similar funds

Oppenheimer & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Oppenheimer & Co held 1,352 positions worth $3.43B, up 2.2% from $3.35B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2016 filing shows 131 new, 487 increased, 534 reduced and 83 closed positions. Its largest new stake was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M. The largest sale was GE Aerospace, an estimated $9.73M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Oppenheimer & Co's largest Q3 2016 buy was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M.
  • Oppenheimer & Co added most to Bristol-Myers Squibb in Q3 2016, an estimated $6.72M increase.
  • Oppenheimer & Co's biggest Q3 2016 reduction was GE Aerospace, cutting an estimated $9.73M.
  • Oppenheimer & Co fully exited Agrium in Q3 2016, selling an estimated $3.32M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.43B portfolio in Q3 2016.
  • Oppenheimer & Co opened 131 new positions and closed 83 in Q3 2016.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $3.43B.

Based on Oppenheimer & Co's 13F filing for Q3 2016, filed 7 Nov 2016.